Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Filings indexed 547 across all filing types
Latest filing 2021-12-06 Regulatory Filings
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
PDS Phase 2 Clinical Trial Update
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from NetScientific plc regarding a clinical trial update for its portfolio company, PDS Biotechnology. It provides a summary of the trial status and directs readers to the full announcement on the PDS website. Since it is a general regulatory announcement that does not fit into specific categories like financial reports or board changes, and is distributed via the RNS platform, it is classified as a Regulatory Filing.
2021-12-06 English
$1million investment in portfolio company, EpiBone
Regulatory Filings Classification · 98% confidence The document is a press release issued by NetScientific PLC regarding a $1 million investment in a portfolio company, EpiBone. It details the nature of the investment, the strategic rationale, and provides background information on the companies involved. It is distributed via the RNS Reach service, which is used for non-regulatory corporate announcements. Since it describes a specific financing/investment activity rather than a general regulatory filing or a report publication announcement, it falls under the category of Capital/Financing Update.
2021-11-26 English
PDS Reports Q3 2021 Results & Business Update
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement issued by NetScientific PLC regarding the financial results and business update of its portfolio company, PDS Biotechnology. While it contains financial highlights, it is an announcement of a report rather than the full financial report itself, and it explicitly provides a link to the full announcement on the PDS Biotechnology website. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement.
2021-11-10 English
Sofant Signs EUR7.3m ESA Contract
Regulatory Filings Classification · 98% confidence The document is a press release issued via the RNS (Regulatory News Service) platform, specifically labeled as 'Reach' (a non-regulatory news service). It announces a business development: a portfolio company (Sofant) signing a contract with the European Space Agency. This does not fit into specific financial reporting categories like 10-K, ER, or IR, nor is it a report publication announcement (RPA) for a formal company report. As it is a general corporate announcement regarding business operations and partnerships, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2021-11-04 English
PDS to License Novel Proteins for Flu Vaccine
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's 'Reach' service. It announces a business development agreement involving a portfolio company (PDS Biotechnology) of NetScientific plc. Since it is a general corporate announcement regarding business operations and does not fit into specific categories like financial reports, dividends, or board changes, it falls under the 'Regulatory Filings' (RNS) category as a general corporate news release.
2021-11-01 English
EMV Capital Participates in £843k Sofant Funding
Regulatory Filings Classification · 98% confidence The document is a press release issued via the RNS Reach service regarding a specific investment transaction (a £843k fundraise for Sofant Technologies). It details the company's participation in a financing round, which falls under the category of capital and financing updates. It is not a regulatory filing, annual report, or earnings release, but rather a corporate announcement of a capital-related activity.
2021-10-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.